- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01645904
A Social Media Approach to Improve Genetic Risk Communication Phase I
Study Overview
Status
Conditions
Detailed Description
If you agree to take part in this study, you will be assigned to 1 of 3 groups based on when you joined the study.
Group 1:
If you are assigned to Group 1, you will take part in a focus group where you will be asked what you would want in a web-based program designed to improve the communication of health and health history information among family members affected by Lynch syndrome. You will also fill out a questionnaire with questions about your demographics (age, race, marital status) and your medical history. This visit should take about 1 hour to complete.
Group 2:
If you are assigned to Group 2, you will come to the Behavioral Research and Treatment Center (BRTC) at MD Anderson to use the initial version of the My Family Garden website. My Family Garden is designed to teach new ways of communicating about Lynch Syndrome and about other issues related to the disease (such as risks associated with the disease, etc.). You will be instructed on how to use the program by the study staff. After you use the website, you will have an interview where you will provide feedback on your session. You will be asked questions about your feelings about the website and about any possible improvements that could be made to the website. You will also fill out a questionnaire called the Website Analysis and MeasureMent Inventory (WAMMI) which is designed help rate websites. You will also fill out the demographics questionnaire described above.
You will be given the option of completing the WAMMI and demographics questionnaire at the BRTC after your session or at your home. If you choose to complete them at home, you will be provided with a self-addressed, postage-paid envelope so you can mail the questionnaires back to the study staff.
This visit should take about 90 minutes to complete.
Group 3:
If you are assigned to Group 3, you will use the final version of the My Family Garden website. This final version will include changes from the web designers after feedback has been given from the previous groups in this study.
After you use the website, you will have an interview where you will provide feedback on your session. You will be asked questions about your feelings about the website and about any possible improvements that could be made to the website. You will also fill out the WAMMI questionnaire and demographics questionnaire described above.
You will be given the option of coming to the BRTC at MD Anderson to use the My Family Garden computer program or using the program from your home. If you choose to use My Family Garden from your home, you will be given a secure, password-protected hyperlink via e-mail to access the program. You will be instructed on how to use the program by the study staff either in person or over the phone. If you use the program from your home, the study staff will give the interview over the phone. If you complete the questionnaire at your home, you will be provided with a self-addressed, postage-paid envelope so you can mail it back to the study staff.
Whether it is completed at MD Anderson or at home, this visit should last about 90 minutes.
Audiotapes:
All focus groups and interviews will be audiotaped. The audiotapes collected during the course of this study will be stored in locked file cabinets in a locked office and will be destroyed after 5 years.
Length of Study Participation:
Your participation in this study will be over after you have completed the study procedures described above.
This is an investigational study.
Up to 49 participants will be enrolled in this study. All participants will be enrolled at MD Anderson.
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Locations
-
-
Texas
-
Houston, Texas, United States, 77030
- University of Texas MD Anderson Cancer Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- At least 18 years of age
- Able to read and speak english
- Completion of genetic counseling and testing for a Lynch syndrome mutation
- Persons with positive (i.e., carrier of Lynch syndrome MMR mutation) as well as indeterminate test results
Exclusion Criteria:
1) None
Study Plan
How is the study designed?
Design Details
- Observational Models: Family-Based
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Group 1
Patients participate in audiotaped focus group regarding web-based program, and fill out demographics questionnaire.
|
Participation in a focus group regarding web-based program designed to improve communication of health and health history information among family members affected by Lynch syndrome.
Complete questions about demographics (age, race, marital status) and medical history.
This visit should take about 1 hour to complete.
Other Names:
|
|
Group 2
Patients come to Behavioral Research and Treatment Center (BRTC) at MD Anderson to use initial version of My Family Garden website.
Completion of Website Analysis and MeasureMent Inventory (WAMMI), and demographics questionnaires.
|
Complete questions about demographics (age, race, marital status) and medical history.
This visit should take about 1 hour to complete.
Other Names:
Group 2: Patients provide feedback regarding initial version of My Family Garden website. Group 3: Patients provide feedback regarding final version of My Family Garden website.
Patients complete Website Analysis and MeasureMent Inventory.
This visit should take about 90 minutes to complete.
|
|
Group 3
Patients use final version of My Family Garden website, and are interviewed which will be audiotaped.
Completion of Website Analysis and MeasureMent Inventory (WAMMI), questionnaire and demographics questionnaire.
|
Complete questions about demographics (age, race, marital status) and medical history.
This visit should take about 1 hour to complete.
Other Names:
Group 2: Patients provide feedback regarding initial version of My Family Garden website. Group 3: Patients provide feedback regarding final version of My Family Garden website.
Patients complete Website Analysis and MeasureMent Inventory.
This visit should take about 90 minutes to complete.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Evaluation of Internet-Based Program Among Lynch Syndrome Family Members
Time Frame: 1 day
|
Quantitative analysis include descriptive statistics summarizing participants' demographic and clinical characteristics.
Descriptive statistics calculated for each subscale of Website Analysis and MeasureMent Inventory (WAMMI) and for overall measure.
Focus groups and interviews transcribed, coded and analyzed.
Responses sorted into categorical and conceptual groups, field notes taken during user testing also used to aid in interpretation of interview data.
|
1 day
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Susan Peterson, MPH, PhD, M.D. Anderson Cancer Center
Publications and helpful links
Helpful Links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2012-0418
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hereditary Diseases
-
Columbia UniversityNatera, Inc.RecruitingHereditary Cancer SyndromeUnited States
-
Pharvaris Netherlands B.V.Enrolling by invitationHereditary Angioedema | Hereditary Angioedema Type I | Hereditary Angioedema Type II | Hereditary Angioedema Types I and II | Hereditary Angioedema Attack | Hereditary Angioedema With C1 Esterase Inhibitor Deficiency | Hereditary Angioedema - Type 1 | Hereditary Angioedema - Type 2 | C1 Esterase Inhibitor... and other conditionsUnited States, Austria, Spain, Australia, Italy, United Kingdom, Bulgaria, France, Germany, Hungary, Israel, Argentina, Canada, Czechia, Hong Kong, Japan, Netherlands, Puerto Rico, South Africa, Sweden, Brazil, Poland, Saudi Arabia, South... and more
-
Pharvaris Netherlands B.V.CompletedHereditary Angioedema | Hereditary Angioedema Type I | Hereditary Angioedema Type II | Hereditary Angioedema Types I and II | Hereditary Angioedema Attack | Hereditary Angioedema With C1 Esterase Inhibitor Deficiency | Hereditary Angioedema - Type 1 | Hereditary Angioedema - Type 2 | C1 Esterase Inhibitor... and other conditionsUnited States, Austria, Australia, Italy, Spain, United Kingdom, Netherlands, Bulgaria, Germany, Hungary, Argentina, Canada, Czechia, France, Hong Kong, Japan, South Africa, Sweden, Brazil, Poland, Saudi Arabia, South Korea, Turkey... and more
-
Pharvaris Netherlands B.V.CompletedHereditary Angioedema | Hereditary Angioedema Type I | Hereditary Angioedema Type II | Hereditary Angioedema Types I and II | Hereditary Angioedema Attack | Hereditary Angioedema With C1 Esterase Inhibitor Deficiency | Hereditary Angioedema - Type 1 | Hereditary Angioedema - Type 2 | C1 Esterase Inhibitor... and other conditionsBulgaria, United States, Spain, Israel, Germany, Poland, Canada, Czechia, France, Hungary, Italy, Netherlands, United Kingdom
-
Pharvaris Netherlands B.V.CompletedHereditary Angioedema | Hereditary Angioedema Type I | Hereditary Angioedema Type II | Hereditary Angioedema Types I and II | Hereditary Angioedema Attack | Hereditary Angioedema With C1 Esterase Inhibitor Deficiency | Hereditary Angioedema - Type 1 | Hereditary Angioedema - Type 2 | C1 Esterase Inhibitor... and other conditionsUnited States, Poland, Germany, Austria, Bulgaria, Canada, Ireland, Italy, United Kingdom
-
ADARx Pharmaceuticals, Inc.RecruitingHereditary Angioedema - Type 1 | Hereditary Angioedema - Type 2 | Hereditary Angioedema (HAE) | HAEUnited States, Argentina, Australia, Belgium, Canada, China, France, Germany, Hong Kong, Israel, Austria, Bulgaria, Croatia, Czechia, Hungary, Poland, Spain, Taiwan, United Kingdom
-
University of UtahUniversity of Witwatersrand, South AfricaCompletedHereditary Elliptocytosis (HE) | Hereditary Pyropoikilocytosis (HPP)United States
-
University of Michigan Rogel Cancer CenterRecruitingHereditary Neoplastic Syndrome | Hereditary Malignant NeoplasmUnited States
-
National Eye Institute (NEI)CompletedHereditary Eye DiseaseUnited States
-
National Eye Institute (NEI)Completed
Clinical Trials on Audiotaped Focus Group
-
NYU Langone HealthCompletedHypertension | High Blood PressureUnited States
-
Queen's University, BelfastCompletedAge Related Macular DegenerationUnited Kingdom
-
Istituto Scientifico Italiano Colonna VertebraleActive, not recruitingAdolescent Idiopathic Scoliosis (AIS)Italy
-
M.D. Anderson Cancer CenterCompletedPediatric CancersUnited States
-
Istanbul University - CerrahpasaRecruitingPatellofemoral Pain, PFPTurkey (Türkiye)
-
Stanford UniversityNational Institute of Mental Health (NIMH)Completed
-
Northwell HealthThe Cleveland Clinic; University of Kansas Medical Center; Cedars-Sinai Medical... and other collaboratorsRecruitingMitral Valve ProlapseUnited States
-
Universitair Ziekenhuis BrusselBrusselse Huisartsenkring (BHAK); Vlaamse Gemeenschapscommissie (VGC)RecruitingPrimary Health Care | Health Services Accessibility | Language | After-hours Care | Communication BarriersBelgium
-
Teesside UniversitySouth Tees Hospitals NHS Foundation TrustNot yet recruitingOveractive Bladder | Urinary Incontinence | Benign Prostatic Hyperplasia | Urinary Tract Infections | Urinary Retention | Underactive Bladder
-
University of Kansas Medical CenterEunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedPregnancy RelatedUnited States